Friday, October 16, 2026

MolDx Withdraws Proposed NonCoverage of Prelude DCISionRT (0360U)

›
 On October 15, 2026, MolDx announced it was canceling its draft non-coverage LCD for Prelude's DCISionRT.  This follows recent announc...
Thursday, October 15, 2026

LabCorp Gets Bioreference, References 4K Score 81539

›
Bioreference acquisitioni by LabCorp features some  carve-outs for  4Kscore behavior.  Here's how it fared in recent Medicare Part B sal...

LabCorp Gets Bioreference: Two AI Viewpoints

›
Below find a Chat GPT and a CLAUDE review of the Labcorp-Bioreference acqiusition.   Each had the same prompt (350-400, use internet). This ...

A Final Reg, A Proposed Bill: Information, Transparency, Coverage

›
 CMS has released a final regulation on (mostly PRICE) transparency in coverage.  See Fed Reg , see Press Release , Fact Sheet .  Here, in t...

Program Integrity - Something New Every Month - Exclusion Authority Added to CMS, Formerly Only the OIG

›
 Medicare's exclusion authorities - kicking you out of the program for 10 or 20 years - was previously handle by the legal eagles in the...

MEDPAC Updates its Basics of Payment series

›
 MEDPAC has a dozen short articles, usually two-pagers, on the different payment systems (one of which is Clin Lab Fee Schedule.) It's s...

Oh Noooo... MACs Forbid Coverage of AI for MRI

›
We saw this LCD topic as Final in February from CGS* and in Draft from Wellpoint Federal, here it comes from Palmetto GBA in draft in Octob...

When Digital Pathology is as much fun as Da Vinci - Sales will Follow

›
 Could AI-drafted pathology reports become something physicians actively want to use —as some surgeons came to love da Vinci robotics?  Thi...
Wednesday, October 14, 2026

AGILENT-Proscia. ROCHE-PathAI. Deep Dives into Business Strategy and Impact

›
  Roche acquires Path AI, Agilent acquires Proscia.  Tempus acquires PAIGE.   In a carefully guided Chat GPT 6 essay, we try to figure out w...

Digital Pathology Association Releases 3 Reimbursement Policy Documents

›
 We're in the run-up to Visions 2026, the annual digital pathology  conference in San Diego this weekend.  Find it here . DPA has releas...

Handy Reference: AMA, ASCO, CAP Positions on the Awful 14-Day Rule

›
The 14-day rule or Date of Service rule is generally unpopular with oncologists and cancer patients and societies.   Here are some recent (2...
Tuesday, October 13, 2026

Agilent to acquire Proscia; Business Strategies in Digital Pathology

›
 In headline news today, Agilent (market cap $50B) will acquire Proscia in a deal for $240M in cash.   See news below. I've had a number...

The Strange World of PAMA Neuro Test Pricing

›
Header.    For 24 neuro codes, most were PLA codes with no PAMA data.   For codes with PAMA data (e.g.  5,000 payments for generic ABeta 1-4...
Monday, October 12, 2026

Using Radiology Business "AI" Section to Understand Trends in 2025-2026

›
 I pulled Radiology Business's own listing of 24 recent AI articles - what does it amount to?  Which way and why, are we running? ### Ye...

Rapid Changes Expected for Breast Cancer Therapies; ADCs and More

›
 From Nature Med, Nat Rev Clin Oncol, and NEJM. ## These papers support a substantial opportunity for digital pathology manufacturers—but th...